Article ID: 693499 Washington University in St. LouisTaking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test. |
Article ID: 693183 Cedars-SinaiScientists have re-created brain neurons of obese patients using "disease in a dish" technology, offering a new method to study the brain's role in obesity and possibly help tailor treatments to specific individuals. Channels: Genetics, Obesity, Personalized Medicine, Cell Biology, Stem Cells, Cell (journal), Local - California, Local - LA Metro, All Journal News Obesity, Personalized Treatment, Personalized Medicine, Precision Medicine, brain neurons, hypothalamic neurons , Cedars-Sinai Board of Governors Regenerative Medicine Institute, Dhruv Sareen |
![]() Article ID: 692594 Ludwig Cancer ResearchLudwig Cancer Research released today the full scope of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, Ill., April 14-18, 2018. Research conducted by more than 100 Ludwig scientists will be presented in symposiums, plenaries, town meetings, education sessions and poster sessions. |
![]()
Article ID: 692610 Perelman School of Medicine at the University of PennsylvaniaA new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients’ own immune cells, which are exposed to the contents of the patients’ tumor cells, and then injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, was a pilot trial aimed primarily at determining safety and feasibility, but there were clear signs that it could be effective: About half of the vaccinated patients showed signs of anti-tumor T-cell responses, and those “responders” tended to live much longer without tumor progression than those who didn’t respond. The study is published today in Science Translational Medicine. Channels: All Journal News, Cancer, Cell Biology, OBGYN, Personalized Medicine, Vaccines, Local - Pennsylvania Ovarian Cancer, personalised medicine, personalized medicine, Clinical Trials, Clinical Trials For Cancer, abramson cancer center, Penn Medicine, Perelman School of Medicine at the University of Pennsylvania, T-cell engineering |
Article ID: 692259 University of Texas M. D. Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center have found a startling amount of new information about molecular features of tumors as well as identified previously unknown cancer subtypes based on a comprehensive analysis of 2,579 tumors from breast and four different types of gynecologic cancers. These new findings potentially could serve as a launching pad for future therapeutic studies. |
|
Article ID: 692216 University Health Network (UHN)The Princess Margaret Cancer Foundation announces the launch of Colour Your Hair to Conquer Cancer, a bold and engaging new fundraising initiative benefiting the Princess Margaret Cancer Centre. |
![]() Article ID: 692162 PhRMA FoundationThe PhRMA Foundation will be partnering with the Personalized Medicine Coalition (PMC) to offer Value Assessment Challenge Awards in 2018, providing more than $80,000 to support scientific papers that advance solutions to a question: What are potentially transformative strategies and methods to define and measure value at all levels of decision making that are aligned with personalized/precision medicine? |
Article ID: 691801 UT Southwestern Medical CenterScientists have found a genetic trigger that may improve the brain’s ability to heal from a range of debilitating conditions, from strokes to concussions and spinal cord injuries. |
Article ID: 691470 Queen's University BelfastResearchers from Queen’s University Belfast have demonstrated for the first time how molecular analysis of clinical trial biopsy samples can be used to help clinicians identify the key changes that occur in an individual patient’s bowel (colorectal) tumour prior to surgery, so clinicians can better understand and treat the disease. |